Feed aggregator

Pros and Cons of the New Digital Pills That Connect to Your Smartphone

Bioethics News - Tue, 11/14/2017 - 15:11

(Quartz) – The health-care community lit up in conversation after news broke that the US Food and Drug Administration (FDA) has approved the world’s first digital drug. It’s a pill that contains a minuscule chip—made of magnesium, silicon, and copper—that can send information from inside the body to an adhesive patch that’s placed on a patient’s torso. The patch can send data to a doctor’s office, as well as to a special smartphone app for those who wish to monitor themselves, until the chip is naturally digested.

Supreme Court Takes on Case about Free Speech and Abortion

Bioethics News - Tue, 11/14/2017 - 14:50

(NPR) – Does a California law violate the Constitution by requiring anti-abortion pregnancy centers to inform clients about free or low-cost abortion and contraception services? That’s the question the Supreme Court is taking on, in a new case it accepted on Monday. California’s Reproductive FACT Act became law in October of 2015. It requires licensed and covered facilities to give all their clients notice that the state “has public programs that provide immediate free or low-cost access to comprehensive family planning services, prenatal care, and abortion, for eligible women.”

Researchers Build a Cancer Immunotherapy without Immune Cells

Bioethics News - Tue, 11/14/2017 - 14:45

(The Scientist) – Engineering an immune cell to recognize and kill a cancer cell is the key to chimeric antigen receptor (CAR) T-cell therapy, but modified immune cells also have the potential to cause problems for patients. One such complication, cytokine release syndrome, is an overreaction of the immune system that can cause symptoms as mild as a fever and as serious as organ dysfunction and death. In a study published today (November 13) in Nature Chemical Biology, researchers have generated nonimmune cells with the ability to kill cancer cells on contact.

The Secret to Long Life? It May Lurk in the DNA of the Oldest Among Us

Bioethics News - Tue, 11/14/2017 - 14:22

(New York Times) – The full genetic sequences of Ms. Michelson, Mr. Harris and Ms. Morano are among some three dozen genomes of North American, Caribbean and European supercentenarians being made available this week by a nonprofit called Betterhumans to any researcher who wants to dive in. A few additional genomes come from people who died at 107, 108 or 109. If unusual patterns in their three billion pairs of A’s, C’s, G’s and T’s — the nucleobases that make up all genomes — can be shown to have prolonged their lives and protected their health, the logic goes, it is conceivable that a drug or gene therapy could be devised to replicate the effects in the rest of us.

New Gene Therapy for Blindness May Soon Be Reality

Bioethics News - Mon, 11/13/2017 - 14:45

(News-Medical) – Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. Patients in the study had a condition called Leber congenital amaurosis (LCA), which begins in infancy and progresses slowly, eventually causing complete blindness. This new, first-of-its-kind gene therapy is currently under review by the U.S. Food and Drug Administration for potential approval this year. There are currently no treatments available for inherited retinal diseases.

Parents Reach Settlement with IVF Clinic after Sons Were Born with Genetic Condition Fragile X Syndrome

Bioethics News - Mon, 11/13/2017 - 14:09

(Sydney Morning Herald) – Before she had her two sons, Leighee Eastbury was told she wasn’t a carrier for Fragile X syndrome, a genetic condition that her boys will now live with for the rest of their lives. It wasn’t until her oldest son Hayden was a toddler that Ms Eastbury learned that she was in fact a carrier and both her boys were affected by the condition which causes intellectual disability. “I was devastated, absolutely devastated, it was something I had a test for … you base all your family planning and everything off that test,” she told reporters on Monday in Sydney.

Scientists grow skin to save Syrian boy’s life

Sanctity of Life News - Sat, 11/11/2017 - 01:00
Skin grown in a lab has been used to treat a boy with a life-threatening condition. Read more...

Let death be didactic

Sanctity of Life News - Sat, 11/11/2017 - 00:53
Why not return to the ancient practice of burying the dead instead of cremating them? Read more...

German serial killer nurse may have killed at least 106

Sanctity of Life News - Sat, 11/11/2017 - 00:45
Niels H abused his position to murder vulnerable people with lethal injections Read more...

Should Facebook have its own chapter in a bioethics text?

Sanctity of Life News - Sat, 11/11/2017 - 00:34
Another challenge for justice and autonomy

Is human gene editing around the corner?

Sanctity of Life News - Sat, 11/11/2017 - 00:28
No, says a stem cell scientist

Choice and non-choice in an organ market

Sanctity of Life News - Fri, 11/10/2017 - 22:21
Is the choice to sell organs a choice we want? Read more...

Woman in minimally conscious state should be allowed to die – UK court

Sanctity of Life News - Fri, 11/10/2017 - 21:25
A British High Court judge has ruled that an elderly woman in minimally conscious state should have artificial feeding withdrawn Read more...

Japanese grant residency to AI chatbot

Sanctity of Life News - Fri, 11/10/2017 - 21:02
A chatbot programmed to be a seven-year-old boy has been granted residency in Tokyo, Japan. Read more...

Targeted by an Addiction Treatment Center, Union Workers Feel Trapped as Their Benefits Are Drained

Bioethics News - Fri, 11/10/2017 - 10:52

(STAT News) – The teachers’ experience is a stark example of what’s happening around the country to union members fighting addiction. Treatment center operators and middlemen who act as brokers for those facilities are targeting these workers because they usually have generous insurance benefits that pay for long stays in rehab. They also often need a health care provider’s clearance to return to work, handing the centers tremendous power over patients.

How to Speed Up Drug and Vaccine Development During a Public Health Crisis

Bioethics News - Fri, 11/10/2017 - 10:38

(STAT News) – The entire process, from basic research to Food and Drug Administration approval, averages about 10 years for drugs and 10 to 15 years for vaccines. A public health crisis doesn’t change the process or let you circumvent any of the steps involved. One way to speed up drug or vaccine development is to leverage existing products through repurposing. That means using an existing drug or vaccine for a different use than the one it was approved for. Because the drug or vaccine has already been tested for safety and is being manufactured, it can likely be rapidly disseminated.

FDA OKs Merk Drug That Prevents Infection Post-Stem Cell Transplant

Bioethics News - Fri, 11/10/2017 - 10:35

(Reuters) – Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday.  Merck said the drug, which is expected to be available from December, was approved both as a tablet and an injection. The list price for the tablets is $195 per day, while it is $270 a day for the injection.The recommended dosing for the drug is once everyday for 100 days after the stem cell transplant, bringing the effective list price to $19,500 for the tablets and $27,000 for the injections.

‘Any Taboo Has Gone’: Netherlands Sees Rise in Demand for Euthanasia

Bioethics News - Fri, 11/10/2017 - 10:25

(The Guardian) – The number of people euthanised in the Netherlands this year is set to exceed 7,000 – a 67% rise from five years ago – in what has been described by the director of the country’s only specialist clinic as the end of “a taboo” on killing patients who want to die. In 2012, 4,188 people were euthanised by doctors in the country, all of whom met the criteria laid down under the 2002 law that made it legal: a voluntary and well considered request in the context of unbearable suffering from which there is no prospect of improvement, or alternative remedy. This year, 18,000 requests for help to die have been made, including 2,500 – up from 1,234 in 2015 – to the Levenseindekliniek – the only medical facility in the Netherlands that specialises in euthanasia.